Previous reports have suggested that ACE inhibitors may be beneficial to dysphagic patients by reducing degradation and inactivation of substance P.58Arai et al.54suggested that Imidapril hydrochloride may increase substance P and reduce the risk of silent aspiration in stroke patients, although the effect size was non‐significant in our meta‐analysis. The gene discussed is TAC1; the disease is Stroke.